Cancer Clinical Trials Need More Patients

by Sarah B. on February 2, 2014 - 10:11pm


According to the Canadian Cancer Society, 2 out of 5 Canadians will be affected by cancer in their life. Something needs to be done in order to stop this illness. To do this, researches have to be done and treatments have to be developed. The problem is that these researches are very expensive. Marilynn Marchione explains this problem in her article "Doctors: Too few cancer patients enrol in studies; many trials end early, slowing progress". When certain experiments are interrupted, people often think that it is because the product did not worked or because it has too many side effects. In reality, clinical trials often ends before the tests are completed because not enough patients participate in these experimental treatments and because there is not enough founding to continue these researches. Also, the patients are often hesitant to participate in these tests because they think that they will not receive sufficient care. However, in cancer clinical trials, the patients will receive the normal treatments and the opportunity to register in some studies.

Overall, patients suffering from cancer should try to enrol in studies to help the researchers find better treatments or new ways to cure this illness. We can also make donations so that the researches will not be interrupted.  This illness has killed too many people that we loved already. We have to help the researchers put an end to it.



Original article from The Gazette

By Marilynn Marchione, posted on January 29, 2014

Statistics from Canadian Cancer Society



About the author